November 11th 2024, 8:00pm
By Alex Biese
Researchers have found an association between baseline circulating tumor cell count and survival in metastatic hormone-sensitive prostate cancer.
November 11th 2024, 6:00pm
By Brian Sluga
When a dear friend told me he has lung cancer, I opened up and shared my own perspective and experience as a survivor of testicular cancer.
November 11th 2024, 5:29pm
By Joseph F. Renzulli MD, FACS
Panelists discuss how implementing targeted strategies can promote equity in treatment for all patients, while offering practical advice for those facing barriers to accessing necessary care for advanced prostate cancer.
Panelists discuss how personal experiences with access- to- care challenges highlight the need for systemic improvements and proactive solutions to ensure that all patients with advanced prostate cancer receive timely and effective treatment.
November 11th 2024, 4:00pm
By Spencer Feldman
Ponsegromab helped patients with cachexia and elevated GDF-15 levels gain weight, increase activity and improve cachexia symptoms, with manageable safety.
November 11th 2024, 2:00pm
By Darlene Dobkowski, MA
If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.
November 10th 2024, 6:00pm
By Catherine Parsons
Susan K. Bohnenkamp, an oncology clinical nurse specialist, is recognized for her compassionate and expert care, going above and beyond to support her patients through their cancer journey.
November 9th 2024, 7:00pm
By Mark Younce
My daughter's diagnosis of a rare and aggressive brain tumor at 3 years old made me strongly consider whether or not to have her treated with radiation.
November 9th 2024, 3:00pm
By Ryan Scott
MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from treatment with targeted therapies.
November 8th 2024, 9:31pm
The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based on findings from the FELIX trial.
November 8th 2024, 8:00pm
Graft-versus-host disease prophylaxis using posttransplant cyclophosphamide remains a valid option for patients with myelodysplastic syndromes.
November 8th 2024, 6:00pm
By Sue McCarthy
After cancer treatment, I wanted to go right back to living my life normally, but a fellow CURE blogger’s post reminded me that rest is necessary too.
November 8th 2024, 4:00pm
By Ashley Chan
From James Van Der Beek spreading awareness about colorectal cancer at a younger age to Gerry Connolly’s recent esophageal cancer diagnosis, here’s what’s happening in the cancer space this week.
November 8th 2024, 2:00pm
The combination of Bavencio and gemcitabine showed promising efficacy and safety in certain patients with advanced leiomyosarcoma.
November 7th 2024, 10:00pm
CURE partnered with City of Hope for a webinar to discuss focusing on quality of life when talking with care teams during breast cancer treatment.
Standing Up to Cancer and How I Do it
Rusfertide Earns Breakthrough Therapy Designation in Polycythemia Vera
Biopsy Alone May Miss Risk in Grade Group 1 Prostate Cancer
HMAs Underutilized in Older, Female and Non-White Patients with MDS